CN Patent

CN101678025A — 四氢生物蝶呤组合物及其测量方法

Assigned to Biomarin Pharmaceutical Inc · Expires 2010-03-24 · 16y expired

What this patent protects

本发明涉及施用四氢生物蝶呤的治疗方法，包括口服剂型、静脉注射制剂和与食物一同施用。本发明还公开了测量样品中生物蝶呤和生物蝶呤的代谢物的量的生物蝶呤测定。

USPTO Abstract

本发明涉及施用四氢生物蝶呤的治疗方法，包括口服剂型、静脉注射制剂和与食物一同施用。本发明还公开了测量样品中生物蝶呤和生物蝶呤的代谢物的量的生物蝶呤测定。

Drugs covered by this patent

Patent Metadata

Patent number
CN101678025A
Jurisdiction
CN
Classification
—
Expires
2010-03-24
Drug substance claim
No
Drug product claim
No
Assignee
Biomarin Pharmaceutical Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.